Pharmaceuticals News and Research

RSS

Healthy lifestyle choices can offset genetic risk for brain diseases

Christopher D. Anderson, MD, MSc, chief of the Division of Stroke and Cerebrovascular Diseases at Brigham and Women's Hospital and associate neurologist in the Department of Neurology and Center for Genomic Medicine at Massachusetts General Hospital, is the corresponding author and Jonathan Rosand, MD, MSc, co-founder of the McCance Center for Brain Health and neurologist in the Department of Neurology and Center for Genomic Medicine at Massachusetts General Hospital, is an author of a paper published on November 6, 2024, in Neurology, the medical journal of the American Academy of Neurology, "Health-related behaviors and risk of common age-related brain diseases across severities of genetic risk."

6 Nov 2024

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Former President Donald Trump has boasted in recent months about "Right To Try," a law he signed in 2018. It's aimed at boosting terminally ill patients' access to potentially lifesaving medications not yet approved by the Food and Drug Administration.

5 Nov 2024

Combination therapy shows promising results in treating stage 3 melanoma

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute (NCI).

1 Nov 2024

Urgent need to shift focus from fossil fuels to health

As multiple health threats from climate change break dangerous new records, the 2024 Report of The Lancet Countdown on Health and Climate Change calls for the trillions of dollars spent funding fossil fuels to be redirected and used to drive a rapid and fair transition to a net zero greenhouse gas (GHG) economy, instead of harming the health of billions of people across the world.

30 Oct 2024

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

The 2024 National Foundation for Cancer Research (NFCR) Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted with the AIM-HI Accelerator Fund, convened the world's top experts across cancer research, biotech entrepreneurship, pharmaceuticals, investment, and patient advocacy.

28 Oct 2024

Tertiary lymphoid structures linked to improved outcomes in liver cancer patients

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center.

25 Oct 2024

Study reveals misuse of scientific evidence by opioid makers

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that makers and marketers of prescription opioid painkillers misused scientific evidence to advance five common and inaccurate claims about the safety and effectiveness of prescription opioids-;including that they were not addictive.

25 Oct 2024

Urine RNA analysis shows promise for detecting genitourinary diseases

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools.

23 Oct 2024

New chemical language model can predict dual-target drug candidates

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties.

23 Oct 2024

Rising asthma rates in sub-Saharan Africa linked to urbanization and lack of care

Rapid urbanization and population growth in sub-Saharan Africa has increased the incidence of asthma in young people, but the lack of diagnosis and care means that many young people are suffering from untreated symptoms of asthma, according to research from Queen Mary University of London.

21 Oct 2024

Medicare drug plans are getting better next year. some will also cost more.

When Pam McClure learned she'd save nearly $4,000 on her prescription drugs next year, she said, "it sounded too good to be true." She and her husband are both retired and live on a "very strict" budget in central North Dakota.

21 Oct 2024

Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition

The CVS representative popped into Lisa Trumble's third-floor Berkshire Medical Center hospital room in Pittsfield, Massachusetts, to announce that everything was arranged for Trumble to return home, where she relies on IV nutrition because of severe intestinal problems that leave her unable to eat.

18 Oct 2024

California continues progressive policies, with restraint, in divisive election year

This year, Gov. Gavin Newsom affirmed abortion access, calling California "a proud reproductive freedom state" and criticizing Republicans across the country for trying to take away families' rights.

18 Oct 2024

A novel biomonitoring method reveals neurotoxic chemical mixtures in human blood

Studies of chemicals in our blood typically capture only a small and unknown fraction of the entire chemical universe. Now, a new approach aims to change that.

18 Oct 2024

Black prostate cancer patients respond better to immunotherapy

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

17 Oct 2024

WHO confirms elimination of trachoma in South Asia

The world moved closer to eliminating trachoma this month after the World Health Organization (WHO) confirmed India and Pakistan as being free of the disease, a leading cause of blindness.

16 Oct 2024

Distinct immune profiles linked to adverse reactions from immunotherapy

Distinct immune "signatures" in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

15 Oct 2024

SU2C announces grants to support cutting-edge research in a variety of cancers

Stand Up To Cancer (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.

15 Oct 2024

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board.

From Calluna Pharma 14 Oct 2024

Study reveals how bacterial selfishness affects antibiotic resistance strategies

As strains of pathogens resistant to frontline antibiotics become more common worldwide, clinicians are more often turning to combination treatments that degrade this resistance as a first treatment option.

10 Oct 2024

1
2
3
4
...
1267
Next

Pharmaceuticals News and Research

Healthy lifestyle choices can offset genetic risk for brain diseases

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Combination therapy shows promising results in treating stage 3 melanoma

Urgent need to shift focus from fossil fuels to health

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

Tertiary lymphoid structures linked to improved outcomes in liver cancer patients

Study reveals misuse of scientific evidence by opioid makers

Urine RNA analysis shows promise for detecting genitourinary diseases

New chemical language model can predict dual-target drug candidates

Rising asthma rates in sub-Saharan Africa linked to urbanization and lack of care

Medicare drug plans are getting better next year. some will also cost more.

Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition

California continues progressive policies, with restraint, in divisive election year

A novel biomonitoring method reveals neurotoxic chemical mixtures in human blood

Black prostate cancer patients respond better to immunotherapy

WHO confirms elimination of trachoma in South Asia

Distinct immune profiles linked to adverse reactions from immunotherapy

SU2C announces grants to support cutting-edge research in a variety of cancers

Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board

Study reveals how bacterial selfishness affects antibiotic resistance strategies

Pittcon Highlights: Pharmaceutical & Biologic eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News